Phenotyping the responses to systemic corticosteroids in the management of asthma attacks (PRISMA)
We found that objective improvement following OCS is confined to T2-High events. As in chronic asthma, greater T2 burden identifies a distinct clinical and therapeutic trajectory, whereas OCS‑related adverse events are uniformly distributed.
Authors
- Pierre Larivée (ORCID: https://orcid.org/0009-0000-9600-9533)
- C.A. Celis-Preciado (ORCID: https://orcid.org/0000-0001-8405-4513)
- Felix-Antoine Vézina (ORCID: https://orcid.org/0009-0008-1675-0531)
- Philippe Lachapelle (ORCID: https://orcid.org/0000-0001-9290-1823)
- Dominic O. Cliché
- Simon Lévesque (ORCID: https://orcid.org/0000-0002-4356-9702)
- Simon Couillard (ORCID: https://orcid.org/0000-0002-4057-6886)
- Simon Leclerc (ORCID: https://orcid.org/0009-0003-0936-5647)
- Martine Duval
- Samuel Lemaire-Paquette
- Lucie Brazeau
- Marylène Dussault
Institutions
- Université de Sherbrooke (CA)
- Centre Hospitalier Universitaire de Sherbrooke (CA)
- Centre Intégré Universitaire de Santé et de Services Sociaux du Saguenay–Lac-Saint-Jean (CA)
- Centre Intégré Universitaire de Santé et de Services Sociaux du Centre-Sud-de-l'Île-de-Montréal (CA)
- Hospital Universitario San Ignacio (CO)
Publication Details
- Journal
- European Respiratory Journal
- Published
- 2025-02-13
- DOI
- https://doi.org/10.1183/13993003.02391-2024
- Citations
- 21
- Primary Topic
- Asthma and respiratory diseases
- Type
- article
- Field-Weighted Citation Impact
- 24.45
Funders
- Regeneron Pharmaceuticals
- bioMérieux
- Sanofi Genzyme